SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

Riluzole ALS Trials

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-clinical-trials-riluzole-als
Related Entities
clinical-trials-riluzole-als
Metadata
slugclinical-trials-riluzole-als
entity_typeclinical
kg_node_idNone
Linked Artifacts (283)
mentions🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme60%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t60%
mentions🔬What are the mechanisms underlying rna binding protein dysre60%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
mentions🔬Analyze the spectrum of microglial activation states (DAM, h60%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
mentions🔬RNA binding protein dysregulation across ALS FTD AD60%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes60%
mentions🔬RNA binding protein dysregulation across ALS FTD and AD60%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%
related🧫Metabolic Pathway-Targeted Therapy in ALS60%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model60%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
related🧫Brainstem Circuit Modulation for PSP60%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT60%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen60%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio60%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%
related🧫N-of-1 Clinical Trial Design for CBS/PSP60%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers60%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%
related🧫Progranulin Replacement Therapy for FTD — Vector Development60%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%
related🧫PSP and CBS Biomarker Validation Study60%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%
related🧫TDP-43 PET Ligand Development for FTD and ALS60%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%
see_also📖ABCA1 - ATP-Binding Cassette Transporter A160%
see_also📖a2m60%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming55%
mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors55%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro55%
related🧪Adenosine-Astrocyte Metabolic Reset55%
related🧪Noradrenergic-Tau Propagation Blockade55%
related🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro55%
related🧪Circadian-Gated Maresin Biosynthesis Amplification55%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th55%
related🧪Mitochondrial SPM Synthesis Platform Engineering55%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer55%
related🧪APOE Isoform Conversion Therapy55%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones55%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction55%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy55%
related🧪APOE4-Selective Lipid Nanoemulsion Therapy55%
related🧪Competitive APOE4 Domain Stabilization Peptides55%
related🧪APOE Isoform Expression Across Glial Subtypes55%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal55%
related🧪SASP-Driven Aquaporin-4 Dysregulation55%
related🧪Aquaporin-4 Polarization Rescue55%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors55%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna55%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes55%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation55%
related🧪Lysosomal Membrane Repair Enhancement55%
related🧪Extracellular Vesicle Biogenesis Modulation55%
related🧪Temporal Decoupling via Circadian Clock Reset55%
related🧪Circadian Clock-Autophagy Synchronization55%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors55%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor55%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri55%
related🧪CYP46A1 Overexpression Gene Therapy55%
related🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor55%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset55%
related🧪Transcriptional Autophagy-Lysosome Coupling55%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming55%
related🧪Liquid-Liquid Phase Separation Modifier Therapy55%
related🧪Stress Granule Phase Separation Modulators55%
related🧪Phase-Separated Organelle Targeting55%
related🧪RNA Granule Nucleation Site Modulation55%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation55%
related🧪Targeted Butyrate Supplementation for Microglial Phenotype M55%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue55%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition55%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization55%
related🧪The Glial Ketone Metabolic Shunt Hypothesis55%
related🧪Axonal RNA Transport Reconstitution55%
related🧪Lysosomal Enzyme Trafficking Correction55%
related🧪Lysosomal Positioning Dynamics Modulation55%
related🧪Lysosomal Calcium Channel Modulation Therapy55%
related🧪Mitochondrial Transfer Pathway Enhancement55%
related🧪APOE-Dependent Autophagy Restoration55%
related🧪Nucleolar Stress Response Normalization55%
related🧪Microglial Purinergic Reprogramming55%
related🧪Purinergic P2Y12 Inverse Agonist Therapy55%
related🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption55%
related🧪Extracellular Matrix Stiffness Modulation55%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation55%
related🧪Perforant Path Presynaptic Terminal Protection Strategy55%
related🧪Arginine Methylation Enhancement Therapy55%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc55%
related🧪Mitochondrial-Lysosomal Contact Site Engineering55%
related🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy55%
related🧪R-Loop Resolution Enhancement Therapy55%
related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme54%
related🔬What are the mechanisms underlying tdp-43 phase separation t54%
related🔬What are the mechanisms underlying rna binding protein dysre54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🔬Analyze the spectrum of microglial activation states (DAM, h54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🔬RNA binding protein dysregulation across ALS FTD AD54%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes54%
related🔬RNA binding protein dysregulation across ALS FTD and AD54%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr54%
related🧫Metabolic Pathway-Targeted Therapy in ALS54%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker54%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model54%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%
related🧫Brainstem Circuit Modulation for PSP54%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT54%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study54%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen54%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio54%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%
related🧫N-of-1 Clinical Trial Design for CBS/PSP54%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers54%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic54%
related🧫Progranulin Replacement Therapy for FTD — Vector Development54%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD54%
related🧫PSP and CBS Biomarker Validation Study54%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen54%
related🧫TDP-43 PET Ligand Development for FTD and ALS54%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%
mentions🧫Blood-Based Biomarker Panel for Early AD Detection50%
mentions🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka50%
mentions🧫Vascular Contribution to Alzheimer's Disease — Beyond A50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
mentions🧪Vocal Cord Neuroplasticity Stimulation50%
mentions🧪Vagal Afferent Microbial Signal Modulation50%
mentions🧫Mouse Cdk5, p35, and p39 mutations in neuronal migration50%
mentions🧫Reelin pathway defects in human type 2 lissencephaly50%
mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 50%
mentions🧫Prion Strain Diversity and Selective Vulnerability50%
mentions🧫MAP6 depletion effects on neuronal development in primary cu50%
mentions🧫Microtubule domain analysis in adult axons50%
mentions🧫Tau depletion effects on neuronal development in primary cul50%
mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers50%
mentions🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro50%
mentions🧪Noradrenergic-Tau Propagation Blockade50%
mentions🧪Circadian-Gated Maresin Biosynthesis Amplification50%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%
mentions🧪Mitochondrial SPM Synthesis Platform Engineering50%
mentions🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 50%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%
mentions🧪Aquaporin-4 Polarization Rescue50%
mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%
mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%
mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%
mentions🧪SASP-Mediated Complement Cascade Amplification50%
mentions🧪Complement C1q Mimetic Decoy Therapy50%
mentions🧪Complement C1q Subtype Switching50%
mentions🧪Complement C1QA Spatial Gradient in Cortical Layers50%
mentions🧪Lysosomal Membrane Repair Enhancement50%
mentions🧪Extracellular Vesicle Biogenesis Modulation50%
mentions🧪Temporal Decoupling via Circadian Clock Reset50%
mentions🧪Circadian Clock-Autophagy Synchronization50%
mentions🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists50%
mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors50%
mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%
mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%
mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
mentions🧪Ephrin-B2/EphB4 Axis Manipulation50%
mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%
mentions🧪Transcriptional Autophagy-Lysosome Coupling50%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%
mentions🧪Stress Granule Phase Separation Modulators50%
mentions🧪Phase-Separated Organelle Targeting50%
mentions🧪RNA Granule Nucleation Site Modulation50%
mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations50%
mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
mentions🧪CX43 hemichannel engineering enables size-selective mitochon50%
mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho50%
mentions🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution50%
mentions🧪Senescence-Induced Lipid Peroxidation Spreading50%
mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%
mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%
mentions🧪Orexin-Microglia Modulation Therapy50%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%
mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%
mentions🧪HDAC3-Selective Inhibition for Clock Reset50%
mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%
mentions🧪Axonal RNA Transport Reconstitution50%
mentions🧪HSP90-Tau Disaggregation Complex Enhancement50%
mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%
mentions🧪Glial Glycocalyx Remodeling Therapy50%
mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%
mentions🧪Lysosomal Enzyme Trafficking Correction50%
mentions🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu50%
mentions🧪KDM6A-Mediated H3K27me3 Rejuvenation50%
mentions🧪Lysosomal Positioning Dynamics Modulation50%
mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In50%
mentions🧪LRP1-Dependent Tau Uptake Disruption50%
mentions🧪Lysosomal Calcium Channel Modulation Therapy50%
mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati50%
mentions🧪Mitochondrial Transfer Pathway Enhancement50%
mentions🧪Nucleolar Stress Response Normalization50%
mentions🧪Netrin-1 Gradient Restoration50%
mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%
mentions🧪Microglial Purinergic Reprogramming50%
mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%
mentions🧪PARP1 Inhibition Therapy50%
mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%
mentions🧪Extracellular Matrix Stiffness Modulation50%
mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%
mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%
mentions🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho50%
mentions🧪Arginine Methylation Enhancement Therapy50%
mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc50%
mentions🧪Mitochondrial-Lysosomal Contact Site Engineering50%
mentions🧪Reelin-Mediated Cytoskeletal Stabilization Protocol50%
mentions🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat50%
mentions🧪R-Loop Resolution Enhancement Therapy50%
mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%
mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%
mentions🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK50%
mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%
mentions🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli50%
mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%
mentions🧪Synaptic Vesicle Tau Capture Inhibition50%
mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%
mentions🧪Autophagosome Maturation Checkpoint Control50%
mentions🧪Cryptic Exon Silencing Restoration50%
mentions🧪Glycine-Rich Domain Competitive Inhibition50%
mentions🧪Cross-Seeding Prevention Strategy50%
mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%
mentions🧪Epigenetic Memory Erasure via TET2 Activation50%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr50%
mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%
mentions🧪Blood-Brain Barrier SPM Shuttle System50%
mentions🧪Low Complexity Domain Cross-Linking Inhibition50%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
mentions🧪TREM2-mediated microglial tau clearance enhancement50%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
mentions🧪Quantum Coherence Disruption in Cellular Communication50%
mentions🧪VCP-Mediated Autophagy Enhancement50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio44%
mentions🧫tACS Connectivity Trial in Early Alzheimer's44%
mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design44%
mentions🧫TRIM21-mediated K63-linked ubiquitination of G3BP144%
mentions🧫G3BP1-mediated stress granule assembly via liquid-liquid pha44%
mentions🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 44%
mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr44%
mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model44%
mentions🧫Environmental Exposure Causal Attribution in ALS — Experimen44%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors40%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna40%
related🧪Vocal Cord Neuroplasticity Stimulation40%
related🧪Vagal Afferent Microbial Signal Modulation40%
related🔬What are the mechanisms underlying selective vulnerability o36%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub